Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Landscape of APC, KRAS, TP53, PIK3CA, and MLH1 in Colorectal

NCT04976439 is registered in ClinicalTrials.gov with Dr Cipto Mangunkusumo General Hospital as lead sponsor.

NCT NCT04976439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Landscape of APC, KRAS, TP53, PIK3CA, and MLH1 in Colorectal
Lead sponsor
Dr Cipto Mangunkusumo General Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
June 14, 2021
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apc gene mutation, colorectal cancer, kras mutation-related tumors, mlh1 gene mutation, pik3ca gene mutation, tp53 gene mutation